Leveraging dual-ligase recruitment to enhance degradation via a heterotrivalent PROTAC

21 August 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Proteolysis targeting chimera (PROTAC) degraders are typically bifunctional with one moiety of an E3 ligase ligand connected to one target protein ligand via a linker. While augmented valency has been shown with trivalent PROTACs targeting two binding sites within a given target protein, or used to recruit two different targets, the possibility of recruiting two different E3 ligases within the same compound has not been demonstrated. Here we present dual-ligase recruitment as a strategy to enhance targeted protein degradation. We designed heterotrivalent PROTACs composed of a CRBN, VHL and BET targeting ligand, separately tethered via a branched trifunctional linker. Structure-activity relationships of 12 analogues qualifies AB3067 as the most potent and fastest degrader of BET proteins, with minimal E3 ligase cross-degradation. Comparative kinetic analyses in wild-type and ligase single and double knockout cell lines revealed that protein ubiquitination and degradation induced by AB3067 was contributed by both CRBN and VHL in an additive fashion. We further expand the scope of the dual-ligase approach by developing a hetero-trivalent CRBN/VHL-based BromoTag degrader and a tetravalent PROTAC comprising of two BET ligand moieties. In summary, we provide proof-of-concept for dual-E3 ligase recruitment as a strategy to boost degradation fitness by recruiting two E3 ligases with a single degrader molecule. This approach could potentially delay the outset of resistance mechanisms involving loss of E3 ligase functionality.

Keywords

PROTACs
Proteolysis targeting chimera
targeted protein degradation
E3 ligases
multivalency
ubiquitination
BromoTag
CRBN
VHL
BET proteins

Supplementary materials

Title
Description
Actions
Title
The Supporting Information is available free of charge.
Description
Quantification of EC50 values 95% CI from cellular proliferation and viability assays in RKO, KBM7 and K562 cells; raw kinetic traces for HiBiT-BET degradation of heteotrivalent (23 – 32) and heterotetravalent (86) PROTACs; quantification of Dmax 50 and λmax values with 95% CI from live cell HiBiT-BET degradation assay; uncropped western blots for BET, VHL and CRBN degradation by compounds 23 – 32, 86 and 97 in HEK293 cells; live cell HiBiT-BET degradation for control compounds 93 – 95; western blots and quantification for BromoTag-BRD4 degradation with 97 and AGB1 in BromoTag-BRD4 HEK294 cells; HPLC and HRMS traces for compounds 1, 2, 23 – 32, 86, 93 – 95 and 97.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.